Clinical Trial Update: Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating decitabine added to busulfan/cyclophosphamide conditioning versus standard busulfan/cyclophosphamide conditioning for pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed-lineage Leukemia -rearranged Acute Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decitabine (Decitabine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Conditions | Phase 2, Phase 3 | Status: UNKNOWN